Log in
Enquire now
‌

US Patent 11913952 Methods for detecting peptide/MHC/TCR binding

Patent 11913952 was granted and assigned to PROGNOSYS BIOSCIENCES, INC. on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
1

Patent attributes

Patent Applicant
‌
PROGNOSYS BIOSCIENCES, INC.
1
Current Assignee
‌
PROGNOSYS BIOSCIENCES, INC.
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
119139521
Patent Inventor Names
John Andrew Altin1
Mark S. Chee1
Date of Patent
February 27, 2024
1
Patent Application Number
175327281
Date Filed
November 22, 2021
1
Patent Citations
‌
US Patent 7378242 DNA sequence detection by limited primer extension
1
‌
US Patent 7393665 Methods and compositions for tagging and identifying polynucleotides
1
‌
US Patent 7407757 Genetic analysis by sequence-specific sorting
1
‌
US Patent 7537897 Molecular counting
1
‌
US Patent 7544473 Nucleic acid analysis using sequence tokens
1
‌
US Patent 7579153 Isothermal DNA amplification
1
‌
US Patent 7635566 Methods and compositions for isolating nucleic acid sequence variants
1
‌
US Patent 7666612 Methods for protein labeling based on acyl carrier protein
1
...
Patent Primary Examiner
‌
Sahana S Kaup
1
CPC Code
‌
G01N 2333/70539
1
‌
C07K 7/08
1
Patent abstract

Provided herein are compositions and methods for detecting the binding of a peptide to an MHC molecule, and the binding of a peptide:MHC complex to a TCR. In preferred embodiments, the compositions and methods are in a highly-multiplexed way. The compositions and methods disclosed herein can be used to provide direct information on which peptides are bound to an MHC molecule. Also provided is a method for simultaneously detecting a large number of peptides for binding to an MHC molecule and/or a T cell. A method for detecting competitive binding of a large number of peptides to an MHC molecule and/or a T cell is also disclosed. Also provided herein is a method for simultaneously detecting a large number of specific TCRs. The compositions and methods of the present invention are useful for vaccine design, research and monitoring of autoimmune and infectious disease, immunogenicity testing of therapeutics, and tissue typing.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11913952 Methods for detecting peptide/MHC/TCR binding

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.